Merck Diabetes Drugs Include Pancreatitis Risk: FDA
By Shannon Henson ( September 25, 2009, 4:34 PM EDT) -- The U.S. Food and Drug Administration has ordered the labels for Merck & Co. Inc.'s diabetes treatments Januvia and Janumet to be updated to inform the public about the drugs' risk of leading to acute pancreatitis....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.